AI Article Synopsis

  • Researchers developed a new type of drug delivery system using a core-shell structure made from bisphenol A-glycerolate dimethacrylates and polyurethane, which allows for customizable sizes and controlled drug release.
  • The structure was analyzed using various techniques like H NMR, FTIR, and UV-vis, confirming its properties, including increased thermal stability and better drug interaction due to higher cross-link density.
  • Biocompatibility tests showed that this graft copolymer can effectively kill cancer cells over time while supporting cell growth in 3D scaffolds, indicating its potential for medical applications.

Article Abstract

Functionalized ultraviolet photocurable bisphenol A-glycerolate dimethacrylates with tailorable size have been synthesized as the core, which have further been grafted using the diisocyanate chain end of polyurethane (PU) as the shell to create a core-shell structure of tunable size for a controlled drug delivery vehicle. The core-shell structure has been elucidated through spectroscopic techniques like H NMR, FTIR, and UV-vis and their relative shape and size through TEM and AFM morphology. The greater cross-link density of the core is reflected in the higher glass transition temperature, and the improved thermal stability of the graft copolymer is proven from its thermogravimetric analyses. The flow behavior and enhanced strength of the graft copolymers have been revealed from rheological measurements. The graft copolymer exhibits sustained release of the drug, as compared to pure polyurethane and photopolymer, arising from its core-shell structure and strong interaction between the copolymer and drug, as observed through a significant shifting of absorption peaks in FTIR and UV-vis measurements. Biocompatibility has been tested for the real application of the novel graft copolymer in medical fields, as revealed from MTT assay, cell imaging, and cell adhesion studies. The efficacy of controlled release from a graft copolymer has been verified from the gradual cell killing and ∼70% killing in 3 days vs meager cell killing of ∼25% very quickly in 1 day, followed by the increased cell viability of the system treated with the pure drug. The mechanism of slow and controlled drug release from the core-shell structure has been explored. The fluorescence images support the higher cell-killing efficiency as opposed to a pure drug or a drug embedded in polyurethane. Cells seeded on 3D scaffolds have been developed by embedding a graft copolymer, and fluorescence imaging confirms the successful growth of cells within the scaffold, realizing the potential of the core-shell graft copolymer in the biomedical arena.

Download full-text PDF

Source
http://dx.doi.org/10.1021/acsami.3c19155DOI Listing

Publication Analysis

Top Keywords

graft copolymer
24
core-shell structure
20
controlled drug
12
drug
8
drug delivery
8
delivery vehicle
8
ftir uv-vis
8
cell killing
8
pure drug
8
graft
7

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!